TY  - JOUR
AU  - Abreu-Gonzalez, Rodrigo
AU  - Gallego-Pinazo, Roberto
AU  - Abraldes, Maximino
AU  - Pinilla, Isabel
AU  - Lopez-Galvez, María I
PY  - 2018
DO  - 10.1177/1120672118804079
UR  - https://hdl.handle.net/10668/24999
T2  - European journal of ophthalmology
AB  - Diabetic macular edema is the main cause of blindness in diabetic patients. Vascular endothelial growth factor is involved in diabetic macular edema pathogenesis. Vascular endothelial growth factor inhibitors are an important option in diabetic...
LA  - en
KW  - Anti–vascular endothelial growth factor
KW  - clinical practice
KW  - diabetic macular edema
KW  - optical coherence tomography
KW  - Angiogenesis Inhibitors
KW  - Dexamethasone
KW  - Diabetic Retinopathy
KW  - Drug Implants
KW  - Female
KW  - Fluorescein Angiography
KW  - Glucocorticoids
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - Male
KW  - Ophthalmologists
KW  - Practice Patterns, Physicians'
KW  - Ranibizumab
KW  - Spain
KW  - Surveys and Questionnaires
KW  - Tomography, Optical Coherence
KW  - Vascular Endothelial Growth Factor A
KW  - Visual Acuity
TI  - Management of diabetic macular edema patients in clinical practice in Spain.
TY  - research article
VL  - 29
ER  -